Iguratimod Attenuated Fibrosis in Systemic Sclerosis via Targeting Early Growth Response 1 Expression

Iguratimod was applied in early growth response 1 overexpressed or knockdown human dermal fibroblast, bleomycin pre-treated mice, tight skin 1 mice, and systemic sclerosis skin xenografts.